6:52 am Columbia Labs repurchases 1.4 mln shares of its common stock from Coventry Acquisition, a subsidiary of Actavis (ACT), at $6.08 per share
View todays social media effects on CBRX
View the latest stocks trending across Twitter. Click to view dashboard